Research

Life Sciences & Biotechnology

Title :

Targeting endothelin-1 to mitigate the risk of nitrofibrinogen-governed TE induced by cisplatin chemotherapy

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Cisplatin chemotherapy

Principal Investigator :

Dr. Gunjan Guha, Associate Professor, SASTRA University, Tamil Nadu

Timeline Start Year :

2018

Timeline End Year :

2021

Contact info :

Details

Total Budget (INR):

49,89,600

Organizations involved